Medical Devices; Radiology Devices; Classification of the Liver Iron Concentration Imaging Companion Diagnostic for Deferasirox
fda-device · Food and Drug Administration · Rule · Published 2025-08-21 · Effective 2025-08-21 · 90 FR 40734
Document
Document number
2025-16033
Federal Register citation
90 FR 40734
CFR reference
21 CFR 892
Type
Rule
Action
Final amendment; final order.
Category
fda-device
Sub-agency
Food and Drug Administration
Publication date
2025-08-21
Effective date
2025-08-21
HHS docket
Docket No. FDA-2025-N-2369
Abstract
The Food and Drug Administration (FDA, the Agency, or we) is classifying the liver iron concentration imaging companion diagnostic for deferasirox into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the liver iron concentration imaging companion diagnostic for deferasirox. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.